Drug Development Executive

Drug Development Executive

Share this post

Drug Development Executive
Drug Development Executive
The Buzz Around GLP-1 Microdosing
Clinical/Medical

The Buzz Around GLP-1 Microdosing

Hype vs. Science

Eswar Krishnan, MD's avatar
Eswar Krishnan, MD
May 29, 2025
∙ Paid

Share this post

Drug Development Executive
Drug Development Executive
The Buzz Around GLP-1 Microdosing
Share

How Prevalent Is Microdosing?

While complex data is scarce, the practice is gaining traction, primarily fueled by online discussions and social media platforms. A recent survey even indicated that as many as 36% of GLP-1 users might be microdosing, often learning about the practice through channels like TikTok.

Is this a new phenomenon?

Not at all. Those o…

Keep reading with a 7-day free trial

Subscribe to Drug Development Executive to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Eswar Krishnan
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share